Stay updated on VAX-24 Safety in Older Adults Clinical Trial
Sign up to get notified when there's something new on the VAX-24 Safety in Older Adults Clinical Trial page.

Latest updates to the VAX-24 Safety in Older Adults Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3; no substantive changes to the study details or page functionality were observed.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNew revision v3.4.3 added. Previous revision v3.4.2 removed.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 is shown in the page footer; this is a minor system update that does not affect the study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1, with no apparent changes to core study content or critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, a minor metadata change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded a comprehensive Locations section listing participating study sites across Alabama, Florida, Georgia, Illinois, Kansas, Louisiana, Missouri, Nebraska, North Carolina, Ohio, South Carolina, Texas, Utah, and Virginia. Updated the page revision to v3.3.3.SummaryDifference1%

Stay in the know with updates to VAX-24 Safety in Older Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety in Older Adults Clinical Trial page.